Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FocaL Mass Drug Administration for Vivax Malaria Elimination (FLAME): a Pragmatic Cluster Randomized Controlled Trial in Peru

NCT05690841 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05690841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05690841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FocaL Mass Drug Administration for Vivax Malaria Elimination (FLAME): a Pragmatic Cluster Randomized Controlled Trial in Peru
Lead sponsor
University of California, San Francisco
Phase
Phase 3
Overall status
Recruiting
Start date
October 14, 2024
Completion date
May 1, 2027
Enrollment
7,530 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, plasmodium vivax malaria